• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of the role of MPA as a molecular-targeted therapy in endometrial cancer.

Research Project

Project/Area Number 21592148
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionOsaka Medical College

Principal Investigator

KANEMURA Masanori  大阪医科大学, 医学部, 講師 (40298782)

Co-Investigator(Kenkyū-buntansha) OHMICHI Masahide  大阪医科大学, 医学部, 教授 (10283764)
TERAI Yoshito  大阪医科大学, 医学部, 講師 (90278531)
TANABE Akiko  大阪医科大学, 医学部, 助教 (70454543)
SASAKI Hiroshi  大阪医科大学, 医学部, 助教 (80432491)
Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywords子宮内膜癌 / GPR30 / 上皮間葉形質転換 / snail / slug / E-cadherin / CD24 / プロゲステロン受容体
Research Abstract

The aims of our study were to evaluate the role of MPA for the regulation of tumor progression. In type 1 endometrial cancer cell line, MPA did not activate both ERK and Akt, However, ERK and Akt were phosphorylated by MPA in type 2 cell line. Interestingly, estradiol(E2) activated ERK and Akt in both cell lines. Therefore, GPR30, a membrane receptor for E2, might be a key molecule for tumor progression in both type 1 and type 2 endometrial cancers. The activation of GPR30 was associated to tumor proliferation via up regulation of cyclin D1.Furthermore, epithelial-mesenchymal-transition(EMT) is recently identified as an important step in the invasion and metastasis of cancer. Our data indicate that reduced E-cadherin and nuclear expression of Snail and Slug have a prognostic impact in endometrial cancer. Therefore, to clarify and control of EMT signaling is a promising molecular targeting therapy in endometrial cancer.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (6 results)

All 2011 2010 2009

All Presentation (6 results)

  • [Presentation] 子宮体癌においてEMT(上皮間葉転換)は予後因子となりえるか2011

    • Author(s)
      田中良道, 金村昌徳、大道正英, etal
    • Organizer
      第50回日本婦人科腫瘍学会学術集会
    • Place of Presentation
      北海道
    • Year and Date
      2011-07-23
    • Related Report
      2011 Annual Research Report
  • [Presentation] 子宮体癌においてEMT(上皮間葉転換)は予後因子となりえるか2011

    • Author(s)
      田中良道, 金村昌徳、大道正英, etal
    • Organizer
      第10回日本婦人科がん分子標的研究会
    • Place of Presentation
      島根
    • Year and Date
      2011-07-02
    • Related Report
      2011 Annual Research Report
  • [Presentation] エストロゲン受容体GPR30の子宮内膜癌における制御機構の解明2011

    • Author(s)
      佐々木浩、金村昌徳大道正英
    • Organizer
      第63回日本産婦人科学会学術講演会
    • Place of Presentation
      大阪
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] 子宮体癌においてEMT(上皮間葉転換)は予後因子となりえるか2011

    • Author(s)
      田中良道、金村昌徳、大道正英
    • Organizer
      第63回日本産婦人科学会学術講演会
    • Place of Presentation
      大阪
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] 子宮体癌におけるE-cadherin, snail, slugの発現意義2010

    • Author(s)
      日中良道、田辺晃子、大道正英
    • Organizer
      第48回日本癌治療学会学術集会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2010-10-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] 子宮内膜癌に対するMPAの作用機序2009

    • Author(s)
      佐々木浩, 金村昌徳
    • Organizer
      第61回 日本産科婦人科学会総会学術講演会
    • Place of Presentation
      京都
    • Year and Date
      2009-04-05
    • Related Report
      2009 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi